ABSTRACT
The need for efficacy of geriatric psychotherapy as well specialized training in geriatric psychosomatics and psychotherapy is commonly recognized amongst professionals. Despite this, this knowledge is not reflected in everyday life. One consequence of this is that psychotherapy for elderly patients is still the exception. We conducted a study in which 478 practicing psychotherapists in Münsterland (Westfalia) were surveyed by mail questionnaire regarding the number and main diagnosis of their patients of greater than 50 years of age, as well as the elderly-specific therapies or future plans for such therapies they might have. The response rate was 65% (312 psychotherapists who answered the questionnaire). The results showed that patients older than 60 years of age were greatly underrepresented compared to younger patients. Moreover, specific therapies, such as age-specific psychotherapy in groups, were rare. To date, it seems that only a minority of elderly patients with psychiatric and psychosomatic diseases are treated adequately by psychotherapy in the outpatient sector. This was evident even in a region such as Münsterland, which has plentiful psychotherapeutic resources.
Subject(s)
Ambulatory Care/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Mental Disorders/therapy , Psychotherapy/statistics & numerical data , Somatoform Disorders/therapy , Aged , Cross-Sectional Studies , Female , Germany , Health Care Surveys/statistics & numerical data , Health Services Needs and Demand/statistics & numerical data , Humans , Male , Mental Disorders/diagnosis , Mental Disorders/epidemiology , Middle Aged , Somatoform Disorders/diagnosis , Somatoform Disorders/epidemiologyABSTRACT
Recently, American authors pronounced the hypothesis that Clozapine-response may be considered as a predictor of response to atypical neuroleptic. We report the history of a schizoaffektive patient unresponsive to butyrophenone and phenothiazine neuroleptic who was first treated with Clozapine and then with Risperidone and who reacted very differently to these atypical neuroleptic.
Subject(s)
Antipsychotic Agents/administration & dosage , Clozapine/administration & dosage , Psychotic Disorders/drug therapy , Risperidone/administration & dosage , Adult , Amitriptyline/administration & dosage , Amitriptyline/adverse effects , Antipsychotic Agents/adverse effects , Clozapine/adverse effects , Depressive Disorder/diagnosis , Depressive Disorder/drug therapy , Depressive Disorder/psychology , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Prognosis , Psychiatric Status Rating Scales , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Risperidone/adverse effects , Treatment OutcomeABSTRACT
UNLABELLED: Repeated partial sleep deprivation (in the second half of the night) is investigated in respect of therapeutic effectivity as part of antidepressive treatment. 31 inpatients suffering from endogenous depression were subjected to walking therapy three times at intervals of one week. RESULTS: The antidepressive efficacy of sleep deprivation is individually (both interindividually and intraindividually) very different. Regular response is rare, but so is repeated non-response. Even if one or several waking therapies remain ineffective, further attempts can eventually result in marked antidepressive effects. Hence a repetition of this antidepressive measure is indicated, the more so since it is easy to carry out and does not produce side effects.
